课题基金 / 基金详情

Type 1 interferon resistance in the HIV-1 envelope glycoprotein

Type 1 interferon resistance in the HIV-1 envelope glycoprotein
HIV-1 包膜糖蛋白中的 1 型干扰素抗性
批准号:
2053983
负责人:
金额:
$0.0万
依托单位:
依托单位国家:
英国
项目类别:
Studentship
财政年份:
2018
资助国家:
英国
项目状态:
已结题
起止时间:
2018 至 --

项目摘要

项目成果

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
A key attribute for the transmission of HIV-1 between individuals is the virus's intrinsic resistance to the antiviral activities of type-1 interferons (IFN-I). Transmitted viruses have a higher resistance to IFN-I than those isolated from the recipient partner 6 months later. The effects of IFN-I on HIV-1 replication are mediated by interferon-induced genes (ISGs), several of which directly inhibit stages of the virus lifecycle. The Interferon-Induced Transmembrane Proteins (IFITMs) are broadly-acting ISGs that target the cell entry process that is mediated by its envelope glycoprotein (Env). We have found that transmitted HIV-1 strains are IFITM resistant but sensitivity increases over time as Env adapts to escape host antibody responses. Insensitivity to IFITMs contributes substantially to the IFN-I resistance of the transmitted virus. Preliminary data suggests that IFITM/IFN resistance of Env correlates with the structural rearrangements it must undergo when it binds to its receptor CD4. The more stable the Env, the more IFITM resistant. Thus the transmitted Env is structurally constrained by the need to be IFN-resistant. Since this is the structure that an effective vaccine needs to protect against, understanding the molecular basis of these constraints is essential. In this project the student will:. use molecular and cellular virology, FRET-based assays and super-resolution microscopy to study how the clustering and dynamics of Env/receptor interactions contribute to IFN/IFITM resistance (Yrs 1-2).. using patient samples from well characterized cohorts, clone and characterize Envs from patients longitudinally and determine how neutralizing antibody escape leads to loss of IFN resistance in Env (Yrs 2-3).
期刊论文(2)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1101/2020.12.19.423592
发表时间: 2020-12
期刊: bioRxiv
影响因子: --
作者: [H. Winstone;M. Lista;A. Reid;S. Pickering;K. Doores;Chad M. Swanson;S. Neil]
通讯作者: H. Winstone;M. Lista;A. Reid;S. Pickering;K. Doores;Chad M. Swanson;S. Neil
DOI: 10.1128/jvi.01250-22
发表时间: 2022-12-14
期刊: Journal of virology
影响因子: 5.4
作者: []
通讯作者:
国内基金
海外基金
系统性探索不同N-glycan修饰对Interferonβ活性和稳定性影响
  • 批准号:
    21877063
  • 项目类别:
    面上项目
  • 资助金额:
    61.4万元
  • 批准年份:
    2018
  • 负责人:
    王鹏
  • 依托单位:
控制肠道病毒71型感染的先天性免疫保护机制及其应用
干扰素信号分子及其调控网络在抗HBV感染过程中的作用机制研究
  • 批准号:
    81171558
  • 项目类别:
    面上项目
  • 资助金额:
    58.0万元
  • 批准年份:
    2011
  • 负责人:
    宁琴
  • 依托单位:
糖药物蛋白Interferonβ N-glycan的均一、人源化改造
  • 批准号:
    81102361
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    25.0万元
  • 批准年份:
    2011
  • 负责人:
    程剑松
  • 依托单位: